Home
News
Create
Screeners
Insights
Ambalal Sarabhai Enterprises
32.
34
+0.44
(+1.38%)
Market Cap
₹247.80 Cr
PE Ratio
19.37
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.38%
1M
-8.93%
6M
-9.26%
1Y
-45.68%
5Y
+75.76%
View Company Insights
Latest news about Ambalal Sarabhai Enterprises
Ambalal Sarabhai Enterprises' Joint Venture CoSara Diagnostics Explores SPAC Merger
2 days ago
CoSara Diagnostics, a joint venture of Ambalal Sarabhai Enterprises (ASE), is exploring strategic options. Co-Diagnostics Inc., ASE's partner, has engaged Maxim Group LLC to investigate possibilities such as a SPAC merger or listing on a U.S. national securities exchange. This move aims to unlock value for CoSara and its shareholders. CoSara, established in 2017, is a partnership between Co-Diagnostics Inc. and Synbiotics Ltd., focusing on molecular diagnostics products for international markets, particularly India.
Ambalal Sarabhai's Telerad Division Clinches Top Broadcast Award at Industry Show
Oct 27, 2025
Ambalal Sarabhai Enterprises Reports Stellar Q1 Performance with 2270% Profit Surge
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation